Combating CoV infections is a massive concern for healthcare systems, owing to the virus's high transmission rate and ability to withstand several mutations. The use of nanotechnology in the diagnosis, treatment, and prevention of COVID-19 has enormous potential. Several nano-based formulations have been demonstrated to increase antiviral medication target delivery and therapeutic efficacy. A new generation of vaccines based on various types of nanomaterials, with better antigen stability, target delivery, and controlled-release, is another promising alternative. The development of technologies for speedy, accurate, and sensitive diagnosis, the manufacturing of effective disinfectants, the delivery of mRNA vaccines into human cells, and the delivery of antiviral medicines into the body are all nanotechnology-based solutions for COVID-19 disease management.
Title : Multicomponent high-entropy cantor alloys
Brian Cantor, University of Oxford, United Kingdom
Title : Threshold switching in nickle-doped zinc oxide based memristor for artificial sensory applications
Rajwali Khan, University of Lakki Marwat, Pakistan
Title : Do nanoscience and nanoengineering need new models for materials and processes?
Elias C Aifantis, Aristotle University of Thessaloniki, Greece
Title : Photoalignment and photopatterning nanosize azodye layers for new liquid crystal devices
Vladimir Chigrinov, The Hong Kong University of Science and Technology, Hong Kong
Title : Nanotechnology in the maintenance of artifacts
Alaa saed abdelmagid zailouk, Ministry of Tourism and Antiquities, Egypt
Title : Metal quantum-dots in glasses for nanophotonics
Purushottam Chakraborty, Saha Institute of Nuclear Physics, India